Results 231 to 240 of about 96,603 (330)

Histological prostatitis and its influence on benign prostatic hyperplasia: a systematic review and meta-analysis. [PDF]

Transl Androl Urol
Wu Y, Yao Y, Zhou B, Fu Y, Yu X, Song L, Zhang Y.   +6 more
europepmc   +1 more source

Functional evaluation of penile hemodynamics [PDF]

, 1988
Bookstein, Brindley, Buvat, Ek, Jevtich, Juenemann, Jünemann, Karacan, Kockott, Lue, Lue, Newman, Porst, Sidi, Stief, van Arsdalen, Virag, Virag, Virag, Virag, Zorgniotti   +20 more
core   +1 more source

Pathology of a Canine Model of Localized Prostate Carcinoma

The Prostate, Volume 86, Issue 1, Page 65-83, January 2026.
ABSTRACT Background Dogs spontaneously develop prostate carcinoma (PC) and share prostate gland anatomy, physiology, and size to men. Over the last 15 years, we have developed and refined a canine model of focal PC to evaluate therapeutic‐diagnostic (theranostic) interventions.
Nathan K. Hoggard, Felipe M. Berg, Marlon R. Szczepaniak, Xinning Wang, Noriko Kantake, Gopalakrishnan Ramamurthy, Li Gong, Eric T. Hostnik, Krishan Kumar, Arijit Ghosh, Dong Luo, Michael V. Knopp, Jill M. Keller, Evan T. Keller, Agata A. Exner, James P. Basilion, Michael F. Tweedle, Thomas J. Rosol   +17 more
wiley   +1 more source

Histoblast: A Novel Cavitative High-Intensity Focused Ultrasound (HIFU)-Modified Technique for Benign Prostatic Hyperplasia. [PDF]

Cureus
Garcia-Gutierrez CM, Garcia-Becerra CA, Garcia-Becerra N, Becerra-Herrejon H, Shoji S, Sanghvi NT.   +5 more
europepmc   +1 more source

Comprehensive Analysis of FOXO1 as a Tumour Suppressor Biomarker Related to Immune Infiltration and Cell Proliferation of Hepatocellular Carcinoma

IET Systems Biology, Volume 20, Issue 1, January/December 2026.
This article systematically analysed the expression patterns and functions of FOXO1 in various cancers through the integration of bioinformatics techniques and basic experiments and conducted indepth exploration in HCC, revealing that FOXO1 may affect the tumour immune microenvironment and regulate the proliferation ability of tumour cells.
Senzhe Xia, Xueqian Qin, Chenggeng Pan, Dingwei Fan, Daqing Yang   +4 more
wiley   +1 more source

Identification of genes related to the effects of bicalutamide and zoladex on benign prostatic hyperplasia. [PDF]

Sci Rep
Peng G, Liang Z, Zuo F, Li J, Han F, Zhang B, Shen H.   +6 more
europepmc   +1 more source

Metabolic Syndrome as a Risk Factor for Developing Benign Prostatic Hyperplasia-A Simple, Non-invasive Method of Transabdominal Ultrasonography for BPH-

, 2006
Takashi Iizuka, Makiko Suzuki, Nana Minamiyama, Akemi Ando, Chie Kuramoto, Takeo Kuwabara, Kunio Yamaguchi   +6 more
openalex   +2 more sources

An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications

The American Journal on Addictions, Volume 35, Issue 1, Page 46-52, January 2026.
Abstract Background Opioid use disorder (OUD) imposes a significant socioeconomic burden, highlighting the need for new interventions. Objective This study investigated whether exposure to 5‐alpha reductase inhibitors (5αRIs) is associated with a lower risk of developing OUD.
Abdelrahman G. Tawfik, Tyler Lister, Ainhoa Gomez‐Lumbreras, Randall T. Peterson, Marco Bortolato, Daniel C. Malone   +5 more
wiley   +1 more source

TERT expression in human prostate tissue reveals a potential molecular switch in benign prostatic hyperplasia progression. [PDF]

World J Urol
Xu Y, Hu S, Berger L, Nicola P, Weinhold P, Tamalunas A, Stief CG, Hennenberg M, Keller P.   +8 more
europepmc   +1 more source

Predicting surgical efficacy and diagnosing histological inflammation: the clinical significance of prostate exosome proteins in benign prostatic hyperplasia

Zhihai Teng, Chenggen Jin, Song Wang, Zhenwei Han, Yanping Zhang, Yaxuan Wang   +5 more
openalex   +1 more source